Medical Student David Geffen School of Medicine at UCLA
Introduction: In 1965, Colombian neurosurgeon Salomón Hakim co-authored a seminal paper with Raymond Adams at the Massachusetts General Hospital (MGH), introducing the world to idiopathic Normal Pressure Hydrocephalus (NPH), a previously unrecognized, treatable cause of dementia. Born in 1922 to Lebanese immigrants, Hakim’s early fascination with physics shaped his insights into brain pathophysiology. After completing medical training at Universidad Nacional in Bogotá, Hakim joined MGH as a research fellow. Observing enlarged ventricles in patients with neurodegenerative diseases, he hypothesized that these patients had a reversible syndrome caused by cerebrospinal fluid (CSF) dynamics. Back in Bogotá, Hakim documented three key cases in 1964, showing that CSF shunting could reverse symptoms of dementia, gait disturbance, and incontinence. Despite initial skepticism, Adams recognized the significance of Hakim’s findings, leading to their collaborative 1965 publication in The Journal of Neurological Sciences. This case series described the groundbreaking NPH triad that redefined neurodegenerative disorders. Notably, Hakim applied Pascal’s Law, proposing that ventricular dilation increased the force exerted on brain tissue even at normal CSF pressures, explaining the paradox of symptomatic hydrocephalus without elevated CSF pressure. Hakim’s ingenuity extended beyond theory; in 1966, he invented a pressure-regulating valve, revolutionizing hydrocephalus treatment by improving the safety and efficacy of shunts. His legacy endures in modern neurosurgery, as his son Carlos continues this line of research developing programmable shunts with designs utilized by Johnson and Johnson and Integra. Hakim’s pioneering work exemplifies the transformative impact of visionary thinking in neurosurgery, inspiring bold approaches to untreatable neurological conditions and profoundly advancing patient care. With a renewed interest in CSF dynamics and drainage to dural lymphatics via arachnoid cuff exit points, and implications in Multiple Sclerosis, Alzheimer’s Disease, and Parkinson’s Disease, Hakim’s story urges the neurosurgery community to boldly innovate ways to treat previously untreatable neuroinflammatory and neurodegenerative diseases.
.jpg)
